search
Back to results

Late In-the-bag intraOcular Lens dislocatioN Surgery (LION)

Primary Purpose

Intraocular Lens Dislocation

Status
Unknown status
Phase
Not Applicable
Locations
Norway
Study Type
Interventional
Intervention
IOL repositioning
IOL exchange
Sponsored by
Oslo University Hospital
About
Eligibility
Locations
Arms
Outcomes
Full info

About this trial

This is an interventional treatment trial for Intraocular Lens Dislocation focused on measuring IOL dislocation, Cataract, Cataract surgery, Scleral suturing, Verisyse, Iris-claw, Late in-the-bag IOL dislocation

Eligibility Criteria

undefined - undefined (Child, Adult, Older Adult)All SexesDoes not accept healthy volunteers

Inclusion Criteria:

  • IOL inside the capsule ("in-the-bag")
  • Late dislocation (more than 6 months after cataract surgery)
  • IOL visible in the pupillary area in the supine position and hence possible to perform surgery with an anterior approach
  • Eligibility for both operation methods
  • Ability to cooperate fairly well during the examinations
  • Willing to participate in the study, e.g. willingness to participate at all control visits

Exclusion Criteria:

  • IOL designs that cannot be repositioned with a suture loop, such as plate-haptic IOLs without holes in the peripheral part
  • Eyes with especially thin sclera
  • Active uveitis or pronounced iris pathology
  • Eyes with previously performed Descemet's Stripping Automated Endothelial Keratoplasty (DSAEK)
  • Totally dislocated IOL into the posterior segment of the eye requiring pars plana vitrectomy
  • Eyes that prior to cataract extraction had a subluxated lens in need of surgery with a Cionni capsular tension ring (e.g. patients with Marfan syndrome and ectopia lentis)
  • Cases requiring a change in refraction. Risk of severe anisometropia
  • Patients unable to lie in supine position for surgery in local anesthesia, e.g. severe chronic obstructive pulmonary disease and severe heart failure
  • Patients using anticoagulants that cannot be discontinued

For patients with dislocated IOLs in both eyes during the study period, only the first operated eye will be included. Patients without prospects of improvement in vision will be excluded.

Sites / Locations

  • Oslo University HospitalRecruiting

Arms of the Study

Arm 1

Arm 2

Arm Type

Active Comparator

Active Comparator

Arm Label

IOL repositioning group

IOL exchange group

Arm Description

Outcomes

Primary Outcome Measures

Inflammation in the anterior chamber after surgery
Measured with a Laser Flare Meter
Changes in macular thickness and occurrence of Cystoid macular edema
Evaluated with Optical Coherence Tomography
Intraocular pressure changes
Measured with Goldmann Applanation Tonometry and iCare, both measured in mmhg

Secondary Outcome Measures

Best Corrected Visual acuity (BCVA)
Measured in LogMar
Best Corrected Visual acuity (BCVA)
Measured in Snellen
Glare
Measured by straylight meter
Glare
Measured by subjective presence of glare
Endothelial cells
Measured by Non-contact corneal confocal microscopy
Intra- and postoperative complications
All relevant complications
IOL tilt
Measured with anterior segment Ultra Sound
IOL tilt
Measured with Anterior segment optical coherence tomography
Refractive outcomes - subjective refraction measured with a phoropter
To compare the refractive outcomes (short and long-term)
Refractive outcomes - subjective refraction measured with a phoropter
To determine whether suture placement for IOL repositioning affects the refractive outcome
Astigmatism
To compare astigmatism measured by keratometry
Astigmatism
To compare astigmatism measured by subjective refraction measured with phoropter

Full Information

First Posted
August 31, 2017
Last Updated
April 16, 2019
Sponsor
Oslo University Hospital
Collaborators
South-Eastern Norway Regional Health Authority
search

1. Study Identification

Unique Protocol Identification Number
NCT03276104
Brief Title
Late In-the-bag intraOcular Lens dislocatioN Surgery
Acronym
LION
Official Title
Late In-the-bag intraOcular Lens dislocatioN Surgery: A Randomized Clinical Trial (LION Trial)
Study Type
Interventional

2. Study Status

Record Verification Date
April 2019
Overall Recruitment Status
Unknown status
Study Start Date
September 9, 2017 (Actual)
Primary Completion Date
November 2020 (Anticipated)
Study Completion Date
December 2022 (Anticipated)

3. Sponsor/Collaborators

Responsible Party, by Official Title
Principal Investigator
Name of the Sponsor
Oslo University Hospital
Collaborators
South-Eastern Norway Regional Health Authority

4. Oversight

Studies a U.S. FDA-regulated Drug Product
No
Studies a U.S. FDA-regulated Device Product
No
Data Monitoring Committee
No

5. Study Description

Brief Summary
Overall aim of the study is to compare the safety and efficacy of two different surgical methods to treat Late In-the-bag intraocular lens dislocation.
Detailed Description
Cataract is a condition of unclear lens that cause poor vision. The only treatment is surgery where the blurred biological lens is replaced with an artificial clear lens (IOL). Most people who operate achieve full vision. Nevertheless, serious complications may occasionally occur, and one of these is dislocation of the entire complex with IOL and lens capsule. This requires surgical treatment. In this study the investigators want to compare two different surgical methods used in late dislocation of IOL inside the capsule after cataract surgery. Patients will be randomly affiliated to either the suturing of existing IOL / capsule complex, or lens exchange to an IOL fixed to the iris. The focus of the trial will be especially on complications and other eye changes in the early stages of surgery. Today, little data is available on these topics, and the investigators believe that new knowledge can bring us closer to a response to preferred operating techniques and an optimal drug drop regime for the patient group.

6. Conditions and Keywords

Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Intraocular Lens Dislocation
Keywords
IOL dislocation, Cataract, Cataract surgery, Scleral suturing, Verisyse, Iris-claw, Late in-the-bag IOL dislocation

7. Study Design

Primary Purpose
Treatment
Study Phase
Not Applicable
Interventional Study Model
Parallel Assignment
Model Description
Randomized clinical trial
Masking
Outcomes Assessor
Masking Description
Masking of research optometrists to group affiliation at the postoperative examinations will be endeavored. A physician will perform slit lamp examinations at the postoperative visits, hence he/she cannot be masked, nor can the surgeon. The investigator will be masked during the image analysis.
Allocation
Randomized
Enrollment
50 (Anticipated)

8. Arms, Groups, and Interventions

Arm Title
IOL repositioning group
Arm Type
Active Comparator
Arm Title
IOL exchange group
Arm Type
Active Comparator
Intervention Type
Procedure
Intervention Name(s)
IOL repositioning
Intervention Description
Intraocular lens repositioning by scleral suturing
Intervention Type
Procedure
Intervention Name(s)
IOL exchange
Intervention Description
Intraocular lens exchange with retropupillary iris-claw lens
Primary Outcome Measure Information:
Title
Inflammation in the anterior chamber after surgery
Description
Measured with a Laser Flare Meter
Time Frame
The first weeks after surgery
Title
Changes in macular thickness and occurrence of Cystoid macular edema
Description
Evaluated with Optical Coherence Tomography
Time Frame
The first months after surgery, and long term changes months up to two years after surgery
Title
Intraocular pressure changes
Description
Measured with Goldmann Applanation Tonometry and iCare, both measured in mmhg
Time Frame
Early changes in the first weeks after surgery, and long term changes months up to two years after surgery
Secondary Outcome Measure Information:
Title
Best Corrected Visual acuity (BCVA)
Description
Measured in LogMar
Time Frame
Short term (the first weeks and up to 6 months) and long term (up to two years)
Title
Best Corrected Visual acuity (BCVA)
Description
Measured in Snellen
Time Frame
Short term (the first weeks and up to 6 months) and long term (up to two years)
Title
Glare
Description
Measured by straylight meter
Time Frame
Medium term (6 months)
Title
Glare
Description
Measured by subjective presence of glare
Time Frame
Medium term (6 months)
Title
Endothelial cells
Description
Measured by Non-contact corneal confocal microscopy
Time Frame
Short term (2 weeks) and long term (6months and 2 years)
Title
Intra- and postoperative complications
Description
All relevant complications
Time Frame
Short term and long term (first post operative day, the first weeks and months, and up to two years)
Title
IOL tilt
Description
Measured with anterior segment Ultra Sound
Time Frame
6 months and 2 years
Title
IOL tilt
Description
Measured with Anterior segment optical coherence tomography
Time Frame
6 months and 2 years
Title
Refractive outcomes - subjective refraction measured with a phoropter
Description
To compare the refractive outcomes (short and long-term)
Time Frame
Short term - meaning 2 weeks to 6 months. Long term - meaning up to two years
Title
Refractive outcomes - subjective refraction measured with a phoropter
Description
To determine whether suture placement for IOL repositioning affects the refractive outcome
Time Frame
Short term - meaning 2 weeks to 6 months. Long term - meaning up to two years
Title
Astigmatism
Description
To compare astigmatism measured by keratometry
Time Frame
Short term - meaning 2 weeks to 6 months. Long term - meaning up to two years
Title
Astigmatism
Description
To compare astigmatism measured by subjective refraction measured with phoropter
Time Frame
Short term - meaning 2 weeks to 6 months. Long term - meaning up to two years

10. Eligibility

Sex
All
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria: IOL inside the capsule ("in-the-bag") Late dislocation (more than 6 months after cataract surgery) IOL visible in the pupillary area in the supine position and hence possible to perform surgery with an anterior approach Eligibility for both operation methods Ability to cooperate fairly well during the examinations Willing to participate in the study, e.g. willingness to participate at all control visits Exclusion Criteria: IOL designs that cannot be repositioned with a suture loop, such as plate-haptic IOLs without holes in the peripheral part Eyes with especially thin sclera Active uveitis or pronounced iris pathology Eyes with previously performed Descemet's Stripping Automated Endothelial Keratoplasty (DSAEK) Totally dislocated IOL into the posterior segment of the eye requiring pars plana vitrectomy Eyes that prior to cataract extraction had a subluxated lens in need of surgery with a Cionni capsular tension ring (e.g. patients with Marfan syndrome and ectopia lentis) Cases requiring a change in refraction. Risk of severe anisometropia Patients unable to lie in supine position for surgery in local anesthesia, e.g. severe chronic obstructive pulmonary disease and severe heart failure Patients using anticoagulants that cannot be discontinued For patients with dislocated IOLs in both eyes during the study period, only the first operated eye will be included. Patients without prospects of improvement in vision will be excluded.
Central Contact Person:
First Name & Middle Initial & Last Name or Official Title & Degree
Marius Dalby, M.D. PhD Cand.
Phone
+47 92408957
Email
marius.dalby@gmail.com
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Liv Drolsum, Prof. M.D. PhD
Organizational Affiliation
Oslo University Hospital
Official's Role
Study Chair
Facility Information:
Facility Name
Oslo University Hospital
City
Oslo
Country
Norway
Individual Site Status
Recruiting
Facility Contact:
First Name & Middle Initial & Last Name & Degree
Olav Kristianslund, M.D. M.Phil. PhD cand.
Phone
+47 41625514
Email
olav.kristianslund@gmail.com

12. IPD Sharing Statement

Plan to Share IPD
No

Learn more about this trial

Late In-the-bag intraOcular Lens dislocatioN Surgery

We'll reach out to this number within 24 hrs